3rd Quarter - Report
PKD FOUNDATION for PKD FOUNDATION
Firm
Client
Income
—
Expenses
$15,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Comprehensive Immunosupressive Drug Coverage for Kidney Transplant Patients Act (HR 2969/S 1454) sought to increase co-sponsors
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY CANTOR | — |
Budget/Appropriations BUD
FY 12 funding for the National Institues of Health (NIH); report language referencing polycystic kidney disease (PKD) to the FY 12 Laborr-Health and Human Services-Educations Appropriations Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY CANTOR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.